Asahi Kasei Therapeutics Corporation
OrganisationROR
Develops
AIC468
8 Oct 2026, businesswire.com
Trials
Phase 3, Completed, 2014, 239 people, 6 Oct 2014, clinicaltrials.gov
Phase 3, Completed, 2014, 250 people, 3 Oct 2014, clinicaltrials.gov
OrganisationROR
AIC468
8 Oct 2026, businesswire.com
Phase 3, Completed, 2014, 239 people, 6 Oct 2014, clinicaltrials.gov
Phase 3, Completed, 2014, 250 people, 3 Oct 2014, clinicaltrials.gov